eMedicine Specialties > Neurology > Neurological Infections

Lyme Disease: Multimedia

Author: Augusto A Miravalle, MD, Fellow, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
Coauthor(s): R Philip Kinkel, MD, FAAN, Associate Professor of Neurology, Harvard Medical School; Director, Multiple Sclerosis Center, Beth Israel Deaconess Medical Center; Consultant Neurologist, Children's Hospital of Boston
Contributor Information and Disclosures

Updated: Jul 23, 2009

Multimedia

Magnified ticks at various stages of development.Media file 1: Magnified ticks at various stages of development.
Magnified ticks at various stages of development.

Magnified ticks at various stages of development.

Typical appearance of erythema migrans, the bull'...Media file 2: Typical appearance of erythema migrans, the bull's-eye rash of Lyme disease.
Typical appearance of erythema migrans, the bull'...

Typical appearance of erythema migrans, the bull's-eye rash of Lyme disease.

Lyme rash. Courtesy of M. Fergione, B. Tucker, an...Media file 3: Lyme rash. Courtesy of M. Fergione, B. Tucker, and L. Zernel; Pfizer Laboratories.
Lyme rash. Courtesy of M. Fergione, B. Tucker, an...

Lyme rash. Courtesy of M. Fergione, B. Tucker, and L. Zernel; Pfizer Laboratories.

Photomicrograph demonstrates perivascular infiltr...Media file 4: Photomicrograph demonstrates perivascular infiltrate in a biopsy specimen from the border of an erythema migrans lesion (hematoxylin and eosin stain). Courtesy of J. Edlow.
Photomicrograph demonstrates perivascular infiltr...

Photomicrograph demonstrates perivascular infiltrate in a biopsy specimen from the border of an erythema migrans lesion (hematoxylin and eosin stain). Courtesy of J. Edlow.

More on Lyme Disease

Overview: Lyme Disease
Differential Diagnoses & Workup: Lyme Disease
Treatment & Medication: Lyme Disease
Follow-up: Lyme Disease
Multimedia: Lyme Disease
References

References

  1. Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P, Chaconas G. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 2008;4(10):e1000169. [Medline].

  2. Bernardino AL, Myers TA, Alvarez X, Hasegawa A, Philipp MT. Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun. Oct 2008;76(10):4385-95. [Medline].

  3. CDC. Division of Vector Borne Infectious Diseases. Lyme disease statistics. 2009. [Full Text].

  4. Wormser GP, Dattwyler RJ, Nadelman RB, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinic Infect Dis. 2006;43:1089-1134.

  5. Rupprecht TA, Pfister HW. What Are the Indications for Lumbar Puncture in Patients with Lyme Disease?. Curr Probl Dermatol. 2009;37:200-206. [Medline].

  6. Roos KL, Berger JR. Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease?. Neurology. Sep 4 2007;69(10):949-50. [Medline].

  7. Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology. Sep 4 2007;69(10):953-8. [Medline].

  8. Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Jul 3 2007;69(1):91-102. [Medline].

  9. Halperin JJ. Nervous system lyme disease: diagnosis and treatment. Rev Neurol Dis. 2009;6(1):4-12. [Medline].

  10. Maraspin V, Strle F. How Do I Manage Tick Bites and Lyme Borreliosis in Pregnant Women?. Curr Probl Dermatol. 2009;37:183-190. [Medline].

  11. American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. American College of Physicians. Ann Intern Med. Dec 15 1997;127(12):1106-8. [Medline].

  12. Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology. Sep 4 2007;69(10):953-8. [Medline].

  13. Callister SM, Schell RF. Laboratory serodiagnosis of Lyme borreliosis. J Spirochetal Tickborne Dis. 1998;5(1):7-10.

  14. Centers for Disease Control and Prevention (CDC). Division of Vector-Borne Infectious Diseases. Learn about Lyme disease. April 10, 2009. CDC Web site. Available at http://www.cdc.gov/ncidod/dvbid/lyme/index.htm.

  15. Eckman MH, Steere AC, Kalish RA, Pauker SG. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med. Jul 31 1997;337(5):357-63. [Medline].

  16. Fallon BA, Nields JA, Burrascano JJ, Liegner K, DelBene D, Liebowitz MR. The neuropsychiatric manifestations of Lyme borreliosis. Psychiatr Q. Spring 1992;63(1):95-117. [Medline].

  17. Fallon BA, Schwartzberg M, Bransfield R, et al. Late-stage neuropsychiatric Lyme borreliosis. Differential diagnosis and treatment. Psychosomatics. May-Jun 1995;36(3):295-300. [Medline].

  18. Fallon BA, Tager F, Keilp J. Repeated antibiotic treatment in chronic Lyme disease. J Spirochetal Tickborne Dis. 1999;6(4):94-102.

  19. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA. Jan 21 1998;279(3):206-10. [Medline].

  20. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med. Jun 1 1998;128(11):931-40. [Medline].

  21. Halperin JJ. Nervous system Lyme disease. Infect Med. 2000;17(8):556-60.

  22. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease).Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Mar 1996;46(3):619-27. [Medline].

  23. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. Jun 1989;39(6):753-9. [Medline].

  24. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. Oct 1991;41(10):1571-82. [Medline].

  25. Harris NS. An understanding of laboratory testing for Lyme disease. J Spirochetal Tickborne Dis. 1998;5(1):16-26.

  26. Liegner KB, Duray P, Agricola M. Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitides. J Spirochetal Tickborne Dis. 1997;4(3):61-73.

  27. Malawista SE. Lyme disease. In: Ceil RL, Bennett JC, Goldman L, eds. Cecil Textbook of Medicine. ed. Philadelphia, Pa: WB Saunders; 2000:1757-61.

  28. McEvoy GK, ed. Lyme disease vaccine. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000:3058-64.

  29. Medscape Today. 12th International Conference on Lyme Disease and Other Spirochetal and Tick-Borne Disorders. New York, NY: April 9-10 1999.

  30. Medscape Today. 13th International Scientific Conference on Lyme Disease and other Tick-borne Disorders. Farmington, CT: March 25-26 2000.

  31. Meurers B, Kohlhepp W, Gold R, Rohrbach E, Mertens HG. Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases. J Neurol. Apr 1990;237(2):113-6. [Medline].

  32. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet. Aug 15 1998;352(9127):557-65. [Medline].

  33. Primavera A, Gazzola P, De Maria AF. Neuropsychological deficits in neuroborreliosis. Neurology. Sep 11 1999;53(4):895-6. [Medline].

  34. Reimers CD, Neubert U. Garin-Bujadoux-Bannwarth syndrome. Lancet. Jul 14 1990;336(8707):128. [Medline].

  35. Schwaiger M, Peter O, Cassinotti P. Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay. Clin Microbiol Infect. Sep 2001;7(9):461-9. [Medline].

  36. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA. Feb 2 2000;283(5):609-16. [Medline].

  37. Sigal LH. The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement. Arch Intern Med. Jul 22 1996;156(14):1493-500. [Medline].

  38. Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed?. Euro Surveill. Jun 22 2006;11(6):E060622.1. [Medline].

  39. Steere AC, Mandell GL. Borrelia burgdorferi (Lyme disease, Lyme borreliosis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 2. 4th ed. New York, NY: Churchhill Livingstone; 1995:2143-55.

  40. Stjernberg L, Berglund J. Detecting ticks on light versus dark clothing. Scand J Infect Dis. 2005;37(5):361-4. [Medline].

  41. Treib J, Fernandez A, Haass A, Grauer MT, Holzer G, Woessner R. Clinical and serologic follow-up in patients with neuroborreliosis. Neurology. Nov 1998;51(5):1489-91. [Medline].

  42. Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med. Jun 29 2006;354(26):2794-801. [Medline].

  43. Wormser GP. Prevention of Lyme borreliosis. Wien Klin Wochenschr. Jun 2005;117(11-12):385-91. [Medline].

  44. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. Nov 1 2006;43(9):1089-134.

  45. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis. Jul 2000;31 Suppl 1:1-14. [Medline].

  46. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. May 6 2003;138(9):697-704. [Medline].

Further Reading

Keywords

Lyme arthritis, Lyme borreliosis, Garin-Boujadoux-Bannwarth syndrome, Garin-Bujadoux-Bannwarth syndrome, Bannwarth syndrome, Borrelia burgdorferi sensu lato, B burgdorferi sensu lato, Borrelia burgdorferi sensu stricto, B burgdorferi sensu stricto, Ixodes ricinus, I ricinus, Borrelia garinii, B garinii, Borrelia afzelii, B afzelii ticks, tick-borne disease, Lyme disease

Contributor Information and Disclosures

Author

Augusto A Miravalle, MD, Fellow, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
Augusto A Miravalle, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Coauthor(s)

R Philip Kinkel, MD, FAAN, Associate Professor of Neurology, Harvard Medical School; Director, Multiple Sclerosis Center, Beth Israel Deaconess Medical Center; Consultant Neurologist, Children's Hospital of Boston
R Philip Kinkel, MD, FAAN is a member of the following medical societies: American Academy of Neurology and Consortium of Multiple Sclerosis Centers
Disclosure: Nothing to disclose.

Medical Editor

Aashit K Shah, MD, Associate Professor of Neurology, Wayne State University; Program Director, Clinical Neurophysiology Fellowship, Department of Neurology, Detroit Medical Center
Aashit K Shah, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, and American Epilepsy Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

CME Editor

Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital
Matthew J Baker, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Chief Editor

Michael K Racke, MD, Professor of Neurology and Molecular Virology, Immunology, and Medical Genetics, Chairman of Neurology, Chief of Neurology Service, Ohio State University Medical Center
Michael K Racke, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Association for the Advancement of Science, American Association of Immunologists, and American Neurological Association
Disclosure: Teva Neuroscience Consulting fee Consulting; Peptimmune Inc. Consulting fee Consulting; Bristol Myers Squibb Consulting fee Consulting; EMD Serono Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.